Johnson Matthey PLC (LON:JMAT) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Johnson Matthey PLC (LON:JMAT) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is GBX 2,010 ($24.83).

A number of research firms have commented on JMAT. Jefferies Financial Group restated a “buy” rating and set a GBX 2,100 ($25.94) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. Berenberg Bank raised their price objective on Johnson Matthey from GBX 1,650 ($20.38) to GBX 1,800 ($22.23) and gave the stock a “hold” rating in a research note on Monday, April 8th. Finally, Numis Securities restated a “buy” rating and set a GBX 2,200 ($27.17) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th.

Johnson Matthey Price Performance

Johnson Matthey stock opened at GBX 1,745 ($21.55) on Friday. The stock’s fifty day moving average price is GBX 1,716.94 and its two-hundred day moving average price is GBX 1,632.25. Johnson Matthey has a one year low of GBX 1,428.50 ($17.64) and a one year high of GBX 1,970.50 ($24.34). The company has a debt-to-equity ratio of 63.95, a current ratio of 1.51 and a quick ratio of 0.76. The firm has a market cap of £3.20 billion, a PE ratio of 1,813.25, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.98.

Insider Activity

In other Johnson Matthey news, insider Stephen Oxley purchased 24 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The shares were bought at an average price of GBX 1,597 ($19.73) per share, for a total transaction of £383.28 ($473.42). In the last quarter, insiders have acquired 66 shares of company stock worth $114,288. Insiders own 0.60% of the company’s stock.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.